Safety of a Single Dose of COMVIGEN Vaccine

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Safety of a Single Dose of COMVIGEN Vaccine trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 2

NCT05930730

Immunogenicity and Safety of Comvigen (Bivalent) Vaccine

This study will assess the safety, reactogenicity and immunogenicity of a single dose of Comvigen (Bivalent, ChulaCov19 BNA159.2) vaccine or BIVALENT Pfizer/BNT…

Thailand450 participantsStarted 2023-10-09

Treatment: Comvigen (Bivalent, ChulaCov19 BNA159.2), BIVALENT Pfizer/BNT vaccine